Research Peptides For Sale

10 Sterile Needles is a research-grade laboratory supply intended for peptide preparation, sterile sample transfer, analytical workflows, and controlled laboratory procedures. Individually sterile and manufactured under stringent quality standards, these laboratory needles support accurate handling of research reagents, sterile diluents, and lyophilized peptide preparations within Research Use Only environments.

A small-molecule nicotinamide N-methyltransferase (NNMT) inhibitor that impacts NAD+ homeostasis, methylation status, and adipocyte gene expression. Investigators use it in models of obesity, insulin resistance, adipose tissue remodeling, and energy expenditure, often alongside NAD+-modulating strategies and sirtuin research. For research use only - not for human or veterinary use, diagnosis, or treatment.

5-Amino-1MQ Spray (5-Amino-1-methylquinolinium) is a research-grade small molecule selective inhibitor of the enzyme nicotinamide N-methyltransferase (NNMT), formulated in a pre-metered liquid vehicle for non-invasive laboratory research. By preventing the methylation of nicotinamide, 5-Amino-1MQ increases intracellular S-adenosylmethionine (SAM) and NAD+ levels, activating SIRT1, AMPK, and downstream mitochondrial biogenesis. Formulated as a stabilized solution, each bottle contains total active compound, analytically verified by HPLC to support reproducible scientific investigations.

AHK-Cu is a research-grade copper peptide formulated for laboratory investigations involving copper-dependent signalling pathways, extracellular matrix biology, and cellular communication systems. Available in both 50mg and 100mg strengths, AHK-Cu is studied in controlled research environments to better understand molecular interactions associated with peptide signalling, tissue-related cellular frameworks, and intracellular regulatory mechanisms. Scientific investigations continue to evaluate AHK-Cu for its role in peptide-mediated signalling, protein regulatory pathways, and extracellular matrix research, making it a valuable compound for molecular and cellular biology studies.

AHK-Cu Spray (Copper Tripeptide-3) is a research-grade synthetic copper-complexed tripeptide formulated in a pre-metered liquid vehicle for non-invasive laboratory research. Consisting of a stabilized aqueous solution with total active peptide, AHK-Cu (sequence: Ala-His-Lys-Cu) selectively complexes with divalent copper (Cu2+). Formulated to study follicular and dermal cellular dynamics, each bottle supports reproducible investigations in extracellular matrix synthesis and localized angiogenesis.

The AHK-Cu Research Pair supplies the copper tripeptide at two fill masses — 50 mg and 100 mg, 150 mg in total. Both vials contain the same compound to the same specification; only the quantity per vial differs. Two fill masses allow a target concentration to be reached at two different prepared volumes. For research use only.

AOD-9604 is a research-grade peptide formulated for laboratory investigations involving growth hormone fragment signaling pathways and metabolic regulatory systems. Available in both 5mg and 10mg strengths, AOD-9604 is studied in controlled research environments to better understand molecular interactions associated with peptide signaling, intracellular communication, and biochemical regulatory mechanisms. Scientific investigations continue to evaluate AOD-9604 for its role in metabolic pathway research, peptide-mediated signalling, and molecular communication networks, making it a valuable compound for endocrine and cellular biology studies.

AOD9604 Spray (Advanced Obesity Drug 9604) is a research-grade synthetic cyclic peptide analog derived from the C-terminus of human Growth Hormone (hGH), formulated in a pre-metered liquid vehicle for non-invasive laboratory research. Representing hGH residues 177-191 with a C-terminal cyclizing tyrosine residue, AOD9604 (sequence: Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe, disulfide bridged) selectively stimulates lipolysis. Formulated as a stabilized solution at a strength of, each bottle supports reproducible lipolytic and fat metabolism investigations.

ARA-290 10mg is a research-grade erythropoietin-derived synthetic peptide formulated for laboratory investigations involving innate tissue-protective receptor signaling, cytokine regulation, inflammatory pathway biology, cellular communication, and peptide-mediated molecular signaling. Each batch undergoes comprehensive analytical verification to ensure purity, consistency, and reproducibility for advanced molecular biology, peptide pharmacology, and immunology research.

ARA-290 Spray (Cibinetide) is a research-grade synthetic 11-amino-acid peptide derived from erythropoietin (EPO), formulated in a pre-metered liquid vehicle for non-invasive laboratory research. Functioning as a highly selective agonist of the Innate Repair Receptor (IRR), ARA-290 (sequence: pyroGlu-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser-OH) is studied for its potent anti-inflammatory, cytoprotective, and neuro-regenerative effects. Formulated as a stabilized solution, each bottle contains total active peptide, analytically verified by HPLC to support reproducible scientific investigations.

Sterile water containing 0.9% benzyl alcohol as a preservative, designed for multi-use vial reconstitution of research compounds. Allows repeated withdrawal from vials and short-term storage of reconstituted materials when handled according to good laboratory practice. For research use only - not for human or veterinary use, diagnosis, or treatment.

A stable pentadecapeptide derived from a gastric protective factor, noted in preclinical work for cytoprotective, pro-angiogenic, and anti-inflammatory actions. Applied in models of tendon/ligament healing, muscle and bone repair, GI mucosal protection, vascular injury, and neurovascular damage, though human data remain limited and controversial. For research use only - not for human or veterinary use, diagnosis, or treatment.

BPC/TB-500 5/5mg Spray is a combined research formulation containing 5mg of BPC-157 and 5mg of TB-500. The two peptides have been investigated separately in preclinical research related to tissue repair, angiogenesis, cellular responses, and inflammation. Direct evidence for the specific combination and spray formulation is much more limited, so the product should be studied as a combined experimental system rather than assuming that findings from either peptide alone establish an effect for the combination.

BPC-157 Spray is a research-grade peptide nasal spray available in 5mg and 10mg strengths, studied for peptide signaling, cellular communication, and tissue biology research.

A combination of TB-500’s actin/angiogenesis signalling with BPC-157’s cytoprotection and growth-factor modulation, used in complex injury scenarios. Research applications include multi-tissue regeneration, multi-site injuries, inflammatory control, and functional recovery in musculoskeletal and soft-tissue systems. For research use only - not for human or veterinary use, diagnosis, or treatment.

The BPC-157 / TB-500 research blend is supplied in two formats: 5 mg/5 mg and 10 mg/10 mg. The notation gives per-component mass, so a 5/5 vial contains 10 mg in total and a 10/10 vial contains 20 mg. Both formats hold the two compounds at a 1:1 ratio. Supplied lyophilized for laboratory reconstitution. For research use only.

Cagrilintide 10mg is a research-grade lyophilized peptide developed for laboratory investigations involving amylin receptor biology, peptide pharmacology, and endocrine signaling. As a long-acting synthetic amylin analogue, it is extensively studied for receptor interactions, neuroendocrine communication, peptide engineering, and metabolic signaling pathways. Every batch undergoes analytical verification to ensure purity, consistency, and reproducibility for advanced laboratory research.

Cagrilintide Spray is a research-grade synthetic acylated amylin analog formulated in a pre-metered liquid vehicle for non-invasive laboratory research. As a long-acting co-agonist targeting both amylin receptors (AMY1, AMY2, AMY3) and calcitonin receptors (CTR), Cagrilintide is investigated for its capacity to stimulate hindbrain satiety pathways, delay gastric emptying, and modulate glucagon secretion. Formulated as a stabilized solution, each bottle contains total active peptide, analytically verified by HPLC to support reproducible scientific investigations in metabolic regulation and mucosal delivery kinetics.

Combination of CJC-1295 (long-acting GHRH analog) and Ipamorelin (GHSR agonist) to produce sustained baseline GH with superimposed pulses. Employed to dissect how different GH-release patterns affect body composition, recovery from training or injury, lipid metabolism, and general anabolic/catabolic balance. For research use only - not for human or veterinary use, diagnosis, or treatment.

CJC/Ipamorelin 5/5mg Spray is a research-grade synergistic peptide blend formulated in a pre-metered liquid vehicle for non-invasive laboratory research. Combining CJC-1295 No DAC (Modified GRF 1-29, GHRH agonist) and Ipamorelin (selective GHSR agonist), this dual-action solution stimulates pulsatile growth hormone secretion via complementary cellular pathways. Formulated as a stabilized solution, each bottle contains 5mg of CJC-1295 No DAC and 5mg of Ipamorelin, analytically verified by HPLC to support reproducible scientific investigations in endocrinology and mucosal transport kinetics.

CJC-1295 No DAC 10mg is a research-grade growth hormone-releasing hormone (GHRH) analog developed for laboratory investigations involving pituitary signaling, pulsatile growth hormone secretion, IGF-1 regulation, endocrine communication, and receptor-mediated molecular pathways. Every batch undergoes comprehensive analytical verification to ensure purity, consistency, and reproducibility for advanced peptide pharmacology, endocrinology, and molecular biology research.

CJC-1295 No DAC spray (also known as Modified GRF 1-29 or Mod GRF 1-29) is a research-grade synthetic GHRH analog formulated in a pre-metered liquid vehicle for non-invasive laboratory research. As a tetrasubstituted 29-amino-acid peptide, it targets GHRH receptors on pituitary somatotrophs to stimulate pulsatile growth hormone secretion. Formulated as a stabilized solution without Drug Affinity Complex (DAC), each bottle contains total active peptide, analytically verified by HPLC to support reproducible scientific investigations in endocrinology and mucosal transport kinetics.

CJC-1295 No DAC 5mg is a research-grade growth hormone-releasing hormone (GHRH) analog developed for laboratory investigations involving pituitary receptor signaling, physiological pulsatile growth hormone release, IGF-1 regulation, endocrine communication, and intracellular molecular pathways. Each batch undergoes comprehensive analytical verification to ensure purity, consistency, and reproducibility for advanced endocrinology, peptide pharmacology, and molecular biology research.

CJC-1295 W/DAC spray is a research-grade synthetic GHRH analog conjugated to a Drug Affinity Complex (DAC), formulated in a pre-metered liquid vehicle for non-invasive laboratory research. Consisting of a modified GHRH(1-29) peptide linked to a maleimidopropionic acid group, it covalently binds to endogenous albumin to evaluate extended, non-pulsatile somatotroph stimulation. Formulated as a stabilized solution, each bottle contains total active peptide, analytically verified by HPLC to support reproducible scientific investigations in endocrinology and mucosal transport kinetics.